0001791864-20-000002.txt : 20200902 0001791864-20-000002.hdr.sgml : 20200902 20200901175408 ACCESSION NUMBER: 0001791864-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200902 DATE AS OF CHANGE: 20200901 EFFECTIVENESS DATE: 20200902 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Synbiotic Health, Inc. CENTRAL INDEX KEY: 0001791864 IRS NUMBER: 815115403 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-374657 FILM NUMBER: 201155248 BUSINESS ADDRESS: STREET 1: 2021 TRANSFORMATION DR STREET 2: SUITE 1250 #6 CITY: LINCOLN STATE: NE ZIP: 68508 BUSINESS PHONE: 402-452-6795 MAIL ADDRESS: STREET 1: 2021 TRANSFORMATION DR STREET 2: SUITE 1250 #6 CITY: LINCOLN STATE: NE ZIP: 68508 FORMER COMPANY: FORMER CONFORMED NAME: Synbiotic Health, LLC DATE OF NAME CHANGE: 20191022 D 1 primary_doc.xml X0708 D LIVE 0001791864 Synbiotic Health, Inc. 2021 TRANSFORMATION DR SUITE 1250 #6 LINCOLN NE NEBRASKA 68508 402-452-6795 DELAWARE Synbiotic Health, LLC Corporation true Timothy Brummels 2021 Transformation Drive, Suite 1250 #6 Lincoln NE NEBRASKA 68508 Executive Officer Director Robert Hutkins 2021 Transformation Drive, Suite 1250 #6 Lincoln NE NEBRASKA Suite 1250 Director Andrew Benson 2021 Transformation Drive, Suite 1250 #6 Lincoln NE NEBRASKA 68508 Director Kevin S Albertsen 2021 Transformation Drive, Suite 1250 #6 Lincoln NE NEBRASKA 68508 Executive Officer Other Decline to Disclose 06b false true false true true Equity securities into which the offered securities are convertible. false 0 1150000 0 1150000 $500,000 of offering is for cash, and $650,000 of offering is in exchange for existing equity securities. false 0 0 0 0 Some of the proceeds from the offering will be used for working capital purposes, which include ordinary course compensation to employees and officers, including those listed in this Form D. false Synbiotic Health, Inc. Timothy Brummels Timothy Brummels Chief Executive Officer 2020-09-01